Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04534348

Acronym

STERILE

Enrollment

598

Registered

2020-09-01

Start date

2017-11-01

Completion date

2020-01-31

Last updated

2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Blood Stream Infection, CLABSI - Central Line Associated Bloodstream Infection

Keywords

CLABSI, CRBSI, Blood Stream Infection

Brief summary

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)

Interventions

DEVICE70% isopropyl alcohol-impregnated catheter caps

Implementation of 70% isopropyl alcohol-impregnated catheter caps in order to assess the number of CLABSI diagnosed during 1 Year

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* every patient in the hemato-oncological department who received at least one CVC was included in the study

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Number of CLABSI	12 Months	To assess the clinical efficacy of Curos in preventing CLABSI in a high-risk department (oncology and ICU)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026